Research Article
Prognostic Value of the Systemic Immune Inflammation Index after Thoracic Endovascular Aortic Repair in Patients with Type B Aortic Dissection
Table 1
Baseline characteristics.
| | General population () | AAE group () | Non-AAE group () | value |
| | Demographics | | Age | | | | 0.001† | | Gender | | | | 0.303‡ | | Male | 149 | 52 (76.8) | 97 (81.8) | | | Female | 37 | 16 (23.2) | 21 (18.2) | | | Histories and comorbidities | | Hypertension | 143 (75.3) | 58 (84.1) | 85 (70.2) | 0.034† | | SBP | 79 (41.6) | 30 (43.5) | 49 (40.5) | 0.688† | | DBP | 80 (42.3) | 35 (50.7) | 45 (37.2) | 0.069† | | Smoking | 54 (28.4) | 21 (30.4) | 33 (27.3) | 0.642‡ | | Alcohol | 22 (11.7) | 5 (7.2) | 17 (14.0) | 0.159‡ | | Diabetes | 16 (8.9) | 4 (5.8) | 12 (10.6) | 0.250‡ | | History of CAD | 9 (4.7) | 1 (1.4) | 8 (6.6) | 0.107‡ | | History of AMI | 1 (0.5) | 0 (0) | 1 (0.8) | 0.341‡ | | History of stroke or TIA | 6 (3.2) | 1 (1.4) | 5 (4.1) | 0.558‡ | | History of CKD | 6 (3.2) | 2 (2.9) | 4 (3.3) | 0.877‡ | | Medication on admission | | Antiplatelet | 8 (4.2) | 2 (2.9) | 6 (5.0) | 0.497‡ | | Anticoagulant | 0 (0) | 0 (0) | 0 (0) | — | | Statin | 5 (2.6) | 1 (1.4) | 4 (3.3) | 0.766‡ | | Intervention | | Intervention phase | 163 (87.4) | 60 (36.7) | 103 (36.7) | 0.923‡ | | Acute | 125 (76.7) | 46 (75.4) | 79 (76.7) | | | Subacute | 26 (15.7) | 9 (15.0) | 17 (16.5) | | | Chronic | 12 (7.2) | 5 (8.3) | 7 (6.7) | | | The location of primary tear | 131 (68.9) | 46 (35.1) | 85 (64.9) | 0.719‡ | | Z3 | 122 (93.1) | 42 (91.3) | 80 (94.1) | | | Z4 | 9 (6.9) | 4 (2.2) | 5 (5.9) | | | PLZ (cm) | | | | 0.841† | | Adjunctive procedure | 9 (4.7) | 4 (5.8) | 5 (4.1) | 0.726‡ | | Postoperative hematological parameters | | Leucocyte (/L) | 90 (48.4) | 35 (51.5) | 55 (46.6) | 0.498† | | Neutrophil (/L) | 135 (72.6) | 51 (75.0) | 84 (71.2) | 0.612† | | Monocyte (/L) | 144 (77.4) | 50 (73.5) | 94 (79.7) | 0.307† | | Lymphocyte (/L) | 80 (43.0) | 36 (52.9) | 44 (37.3) | 0.038† | | Hemoglobin (<130 g/L) | 101 (54.3) | 39 (57.4) | 62 (52.5) | 0.120‡ | | Platelet (<125) | 22 (11.8) | 13 (19.1) | 9 (7.6) | 0.019‡ | | D-dimer | 89 (97.8) | 35 (50.7) | 54 (44.6) | 0.418† | | Fibrinogen (>400) | 111 (60.0) | 40 (58.0) | 71 (58.7) | 0.924‡ | | Albumin (<35) | 41 (22.2) | 19 (27.5) | 22 (18.2) | 0.132‡ | | Serum creatinine | 43 (22.6) | 16 (23.2) | 27 (22.3) | 0.890‡ | | GFR (<100) | 124 (65.3) | 45 (65.2) | 79 (65.3) | 0.992‡ | | Cholesterol | 17 (8.9) | 7 (10.1) | 10 (8.3) | 0.662‡ | | Triglycerides | 30 (15.8) | 6 (8.7) | 24 (19.8) | 0.043‡ | | LDL | 13 (6.8) | 4 (5.8) | 9 (7.4) | 0.667‡ | | HDL | 40 (21.1) | 9 (13.0) | 31 (25.6) | 0.063‡ | | NLR (>6.703) | 100 (53.7) | 44 (64.7) | 56 (47.5) | 0.023‡ | | MLR (>0.591) | 117 (62.9) | 46 (67.6) | 71 (60.2) | 0.300‡ | | PLR (<113.8) | 32 (36.8) | 15 (22.1) | 17 (14.4) | 0.200‡ | | SII (>2893) | 35 (18.4) | 19 (27.9) | 16 (13.6) | 0.016‡ | | SIRI (>3.776) | 132 (71.1) | 53 (77.9) | 79 (66.9) | 0.110‡ |
|
|
SBP = systolic blood pressure; DBP = diastolic blood pressure; CAD = coronary artery disease; AMI = acute myocardial ischemia; CVD = cerebrovascular disease; TIA = transient ischemic attack; CKD = chronic kidney disease; eGFR = estimated glomerular filtration rate; LDL = low-density lipoprotein; HDL = high-density lipoprotein; WBC = white blood cell; NLR = neutrophil-to-lymphocyte ratio; MLR = monocyte-to-lymphocyte ratio; PLR = platelet-to-lymphocyte ratio; SII = the ratio of platelet count multiply neutrophil count to lymphocyte count; SIRI = the ratio of monocyte count multiply neutrophil count to lymphocyte count. †Student’s -test or Mann–Whitney test. ‡Pearson’s chi-square test or Fisher’s exact test. |
